MICHAEL M. FRANK, M.D.; THOMAS J. LAWLEY, M.D.; MAX I. HAMBURGER, M.D.; ERIC J. BROWN, M.D.
▸Requests for reprints should be addressed to Michael M. Frank, M.D.; Building 10, Room 11N228, National Institutes of Health; Bethesda, MD 20205.
FRANK MM, LAWLEY TJ, HAMBURGER MI, BROWN EJ. Immunoglobulin G Fc Receptor-Mediated Clearance in Autoimmune Diseases. Ann Intern Med. 1983;98:206-218. doi: 10.7326/0003-4819-98-2-218
Download citation file:
Published: Ann Intern Med. 1983;98(2):206-218.
The reticuloendothelial system is thought to play an important role in removing immune complexes and other immunologically active substances from the circulation via interaction with specific cell-surface receptors. The function of the reticuloendothelial system in humans with autoimmune diseases was studied in vivo by measuring the rate of removal of IgG-coated, radio-labeled autologous erythrocytes. Such cells are removed by phagocytic cells of the spleen, and the process depends on the presence of an intact IgG Fc fragment. Studies in patients with active systemic lupus erythematosus show a profound defect in Fc-receptor-specific clearance that correlates with disease activity. Patients with other autoimmune diseases have defects in Fc receptor functional activity when their illness is characterized by tissue deposition of immune complexes. Normal patients with HLA-B8/DRw3, an HLA type associated with an increased incidence of autoimmune disease, also have an increased incidence of defective Fc receptor-specific functional activity, suggesting that this defect may predispose patients with this haplotype to develop manifestations of immune complex-mediated disease.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only